The apolipoprotein B Q3405E polymorphism has no effect on its low-density-lipoprotein receptor binding affinity. 1996

C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
Cardiovascular Research Institute, University of California, San Francisco 94143-0130, USA.

A better understanding of the apolipoprotein B100 (apoB100) sequences involved in binding to the low-density lipoprotein (LDL) receptor will be achieved by studying the effects of polymorphisms and rare mutations of apoB100. Upon re-examination of apoB100 DNA sequencing discrepancies, a charge-change polymorphism, Q3405E, was found in the putative LDL receptor binding domain of the protein. Positively charged lysine and arginine side chains of the protein have been demonstrated to participate in the ligand. This led us to propose that the presence of an additional negative charge in close proximity could have an impact on the binding affinity. The polymorphism is the result of a C-to-G transition at nucleotide 10422. Population screening revealed 20 of the less common glutamate alleles at an allele frequency of 0.9%. The effect of the presence of one glutamate allele on the binding affinity of LDL for the LDL receptor was investigated in seven heterozygous individuals by a competitive dual-label fibroblast binding assay. One individual who was homozygous for the glutamate allele was discovered and her LDL examined in a competitive displacement binding assay. The additional negative charge at residue 3405 had no detectable affect on the binding affinity.

UI MeSH Term Description Entries
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D018698 Glutamic Acid A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. Aluminum L-Glutamate,Glutamate,Potassium Glutamate,D-Glutamate,Glutamic Acid, (D)-Isomer,L-Glutamate,L-Glutamic Acid,Aluminum L Glutamate,D Glutamate,Glutamate, Potassium,L Glutamate,L Glutamic Acid,L-Glutamate, Aluminum

Related Publications

C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
December 1995, Journal of lipid research,
C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
February 1992, Arteriosclerosis and thrombosis : a journal of vascular biology,
C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
November 1977, Proceedings of the National Academy of Sciences of the United States of America,
C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
August 1993, Atherosclerosis,
C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
December 1984, The Journal of biological chemistry,
C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
June 1997, Atherosclerosis,
C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
June 1995, Atherosclerosis,
C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
April 1986, Proceedings of the National Academy of Sciences of the United States of America,
C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
January 2000, The Journal of biological chemistry,
C R Pullinger, and J A Love, and W Liu, and L K Hennessy, and M Ghassemzadeh, and K C Newcomb, and D R Illingworth, and J P Kane
October 1988, The Journal of biological chemistry,
Copied contents to your clipboard!